An  article published in the December, 2008 issue of the journal Carcinogenesis <http://carcin.oxfordjournals.org/>  explains how broccoli and  other cruciferous vegetables protect against cancer of the breast.  Increased intake of cruciferous vegetables, which also include  cauliflower, Brussels sprouts and cabbage, has been associated with a  lower risk of breast and other cancers, yet their mechanism of action  against the disease has not been thoroughly explored.
[Read more...]

Thursday, 29 January 2009 00:00

WASHINGTON – The so-called breast cancer genes BRCA1 and BRCA2 can raise the risk that a man who develops prostate cancer will get an aggressive form of the disease, U.S. researchers reported on Thursday. Certain mutations in the genes indicated a man was at risk of more aggressive cancer and should be treated right away, the team at the Albert Einstein College of Medicine of Yeshiva University said. Their study of 2,000 Jewish men shows the gene mutation, more common among Jews of European descent, might help show which men have a slow-growing tumor that may not need immediate treatment.

[Read more...]

NCCN announces new updates to the NCCN Guidelines for Breast Cancer and Breast Cancer Risk Reduction Guidelines. Noteworthy additions include new recommendations on when to use MRIs in breast cancer evaluations, statements discouraging the use of PET/CT scanning for evaluative purposes, and new cosmetic recommendations for women undergoing reconstructive surgery.
For complete story, click here.

A  report published online on April 30, 2008 in the journal Breast Cancer Research   concluded that the use of  aspirin on a daily basis reduced the risk of estrogen receptor-positive  breast cancer, which makes up 75 percent of breast cancer cases. These  cancers have receptors on their surface for female hormone estrogen, which  fuels the tumors’ growth.

[Read more...]

M. D. Anderson Study First to Evaluate Prevalence, Impact of Off Label Chemotherapy in Breast Cancer
Drugs not always approved for reimbursement, despite shown to be efficacious

[ABSTRACT #1016]

ORLANDO – At some point during their care, more than one-third of metastatic breast cancer patients receive chemotherapy off label, the legal use of FDA-approved drugs in a different indication than for which they were approved, according to researchers at The University of Texas M. D. Anderson Cancer Center.

[Read more...]